In a recent article in Endpoints, Astellas highlights its work in gene therapy and commitment to rare diseases, including its collaboration with Kate Therapeutics.
In a recent article in Endpoints, Astellas highlights its work in gene therapy and commitment to rare diseases, including its collaboration with Kate Therapeutics.